The Capital Group Companies, Inc. is now a major shareholder of Zealand Pharma.

From GlobeNewswire: 2024-12-25 11:30:00

Zealand Pharma A/S received a notification from major shareholder, The Capital Group Companies, Inc., on December 23, 2024, indicating voting rights of 6.20% in the company. The shares are held by accounts under investment management of affiliated companies. Zealand Pharma is a biotechnology company focused on peptide-based medicines, with over 10 drug candidates in clinical development. The company has partnerships with pharma companies and commercial partnerships for its marketed products. For more information, visit http://www.zealandpharma.com. Contacts for investors and media are provided.



Read more at GlobeNewswire: Zealand Pharma major shareholder announcement: The Capital